How Should Doctors Explain Biological Age to Their Patients? A Communication Framework

Doctors explaining biological age need a framework that separates the concept from chronological age, grounds it in a measurable biomarker, and gives the patient a clear next action rather than an abstract number. Biological age reflects how fast a person's body, particularly the immune system, is aging relative to the calendar, and it is shaped far more by lifestyle, stress, hormonal status, and medical history than by the year on a birth certificate.

For a deeper look at how this fits into clinical and corporate wellness practice, see GlycanAge for Healthcare Providers, Functional Medicine Clinics & Corporate Wellness Programs.

What is biological age, and how is it different from chronological age?

Biological age measures how fast a person's body is functioning and aging relative to their years lived, while chronological age is simply the number of years since birth. Two people born in the same year can have biological ages a decade apart depending on their lifestyle, stress load, hormonal status, and medical history. Baker and Sprott, who first proposed the concept nearly forty years ago, framed it with a useful thought experiment: at a high school reunion, everyone in the room shares a chronological age, but some attendees will look and function like they did at eighteen, while others will resemble people a decade older. That gap, invisible on a birth certificate but visible in underlying biology, is what biological age testing quantifies. For patients, the simplest framing is this: chronological age tells you how long you have lived; biological age tells you how well. 

Why should I introduce biological age testing into a patient conversation instead of just discussing risk factors?

Biological age gives patients a single, trackable number instead of an abstract risk factor that is hard to act on.

"If I tell someone their relative risk of heart disease is 1.3, all I get is more questions. Is that good or bad? People don't know what to do with that number. But if I say your heart age appears to be forty-five and you're forty, that's something people can actually relate to."

 — Dr. Peter Joshi, Chief Scientist, Humanity Health, and tenured academic, University of Edinburgh 

Biological age works differently. Patients relate to it because it functions as a personal clock, and unlike a relative risk ratio, it can move in response to what they actually do. Framing the conversation around biological age rather than isolated lab values gives patients a number they can watch change over time, which supports adherence far better than a static risk score.

Isn't biological age just another way of predicting how long someone will live?

Biological age is better understood as a current, modifiable signal of health than a fixed prediction of lifespan. Unhealthy habits accelerate biological aging, a healthy lifestyle slows it, and the right interventions can measurably reverse it. This is the framing to give patients directly: the number is not a sentence, it is a snapshot that responds to what they do next. GlycanAge specifically tracks active, current inflammation rather than a historical or genetic signal, which means a patient's result today reflects their biology today, not a fixed trajectory they cannot influence.

How do I explain what's actually being measured, in plain terms a patient will understand?

A biological age higher than chronological age should be framed as a signal of immune system dysregulation and elevated chronic inflammation, not as a diagnosis. This pattern can be driven by genetics, unhealthy lifestyle, or underlying disease, and it is a starting point for investigation rather than a conclusion. Doctors should resist the instinct to over-explain the biology in this first conversation and instead anchor the patient to the actionable frame: this number reflects current immune function, and unlike genetic tests that describe fixed potential, it responds within 3 to 4 months to pharmaceutical or HRT-based interventions, or within 6 to 12 months to lifestyle-based changes such as diet, exercise, or stress management. 

How should I explain a result that's higher than the patient's chronological age?

A biological age higher than chronological age should be framed as a signal of immune system dysregulation and elevated chronic inflammation, not as a diagnosis. This pattern can be driven by genetics, unhealthy lifestyle, or underlying disease, and it is a starting point for investigation rather than a conclusion. Doctors should resist the instinct to over-explain the biology in this first conversation and instead anchor the patient to the actionable frame: this number reflects current immune function, and it responds to intervention within three to six months, unlike genetic tests that describe fixed potential.

How should I explain a result that's lower than expected, especially if it contradicts other clinical findings?

A biological age result that does not match a patient's presentation should prompt a structured follow-up conversation about medications, supplements, and recent life events before any conclusion is drawn. Case documentation from GlycanAge partner clinics shows this pattern repeatedly: results that seem confusing at first are frequently explained once a clinician asks about hormone therapy, off-label longevity protocols, or a recent illness the patient did not think to mention. One documented case tracked a female patient with Hashimoto's thyroiditis (an autoimmune condition affecting the thyroid) over five years. Her biological age rose sharply following pregnancy, then normalized as she recovered and adopted targeted lifestyle changes, with later fluctuations tracking her adherence to those habits. Clients often do not report supplements or off-label interventions because they do not think of them as "medication," which makes the intake conversation essential to correct interpretation. 

"You cannot ask a person and get a truthful answer, especially about diet and habits. We all lie. People don't tell the truth about how much they drink or eat. If you can measure these things, that makes everything better."

— Prof. Gordan Lauc, Professor of Biochemistry and Molecular Biology, University of Zagreb, and Co-Founder & Chief Scientific Officer, GlycanAge

The practical takeaway for clinicians: build a standard intake question set around medications, supplements, and life events before assuming an unexpected result is inaccurate.

What follow-up pathway should I use when a result comes back worse than expected?

A high biological age relative to chronological age should trigger a structured review of core lab investigations, not an immediate change in treatment protocol. Clinics should have a defined follow-up pathway ready for patients whose result is not where the practitioner hoped, particularly patients with genetic or family history predisposing them to cardiovascular disease. This keeps the conversation clinical and proportionate: the result is a prompt for further investigation, not an alarm that requires immediate intervention.

Can I use biological age testing alongside other tests I already run, like standard bloodwork or genetic panels?

Biological age testing through glycans captures a signal that standard blood panels and genetic tests do not, because it measures active inflammation rather than momentary blood chemistry or fixed genetic potential. Glycan-based testing is currently the only commercially available at-home biological age test built on this signal, and it ships to over 65 countries, with a 1:1 result interpretation call patients can book once their results are in. Positioning it to patients as an addition to their existing bloodwork, rather than a replacement, keeps the conversation grounded: standard labs tell you what is happening in the blood right now; glycan-based biological age tells you how the immune system is trending over time. 

How often should a patient retest, and how do I frame that conversation?

Retesting should be framed around the timeline of the intervention being tracked, not a fixed calendar schedule. Because biological age is a concrete, trackable signal, clinicians can identify where inflammaging (chronic, low-grade inflammation that accelerates biological aging) is driving accelerated aging and act on it years before disease develops, rather than waiting for symptoms. The retest conversation should center on what changed: a new supplement protocol, a hormone therapy adjustment, or a lifestyle change all give the patient a reason to look again after a defined window, turning the test into an ongoing feedback loop rather than a one-time verdict.

See how GlycanAge fits your patient consultations. Visit the Healthcare Providers page to review the clinical workflow, sample reporting, and partner onboarding. 

Explore for Healthcare Providers →

External sources

• https://pubmed.ncbi.nlm.nih.gov/3058488/ — Baker GT 3rd, Sprott RL. Biomarkers of aging. Exp Gerontol. 1988;23(4):223-239.